Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.31M Buy
6,574
+9
+0.1% +$3.21K 1.29% 17
2025
Q4
$2.15M Sell
6,565
-603
-8% -$191K 1.21% 19
2025
Q3
$2.02M Buy
7,168
+30
+0.4% +$8.7K 1.1% 20
2025
Q2
$1.99M Sell
7,138
-429
-6% -$122K 1.18% 22
2025
Q1
$2.36M Sell
7,567
-27
-0.4% -$7.97K 1.46% 16
2024
Q4
$1.98M Buy
7,594
+66
+0.9% +$19.6K 1.2% 22
2024
Q3
$2.43M Sell
7,528
-44
-0.6% -$14.4K 1.41% 16
2024
Q2
$2.37M Buy
7,572
+10
+0.1% +$2.94K 1.47% 17
2024
Q1
$2.15M Sell
7,562
-120
-2% -$35.1K 1.34% 19
2023
Q4
$2.21M Sell
7,682
-568
-7% -$155K 1.52% 14
2023
Q3
$2.22M Buy
8,250
+655
+9% +$163K 1.63% 12
2023
Q2
$1.69M Buy
7,595
+193
+3% +$44.8K 1.26% 17
2023
Q1
$1.79M Buy
7,402
+80
+1% +$19.6K 1.42% 18
2022
Q4
$1.98M Buy
+7,322
New +$1.96M 1.63% 11

Other funds holding AMGN

ViaWealth's AMGN Position: Q1 2026 in Review

ViaWealth increased its Amgen (AMGN) stake by 0.14% in Q1 2026, buying an estimated $3.21K and bringing the position to 6,574 shares worth $2.31M. The position accounts for 1.29% of the portfolio, ranked #17.

ViaWealth first reported a position in AMGN in Q4 2022 and has held it in 14 quarters since. The position peaked at $2.43M in Q3 2024. 3,130 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • ViaWealth held 6,574 shares of Amgen worth $2.31M as of Q1 2026.
  • ViaWealth bought 9 Amgen shares in Q1 2026, an estimated $3.21K.
  • Amgen made up 1.29% of ViaWealth's portfolio in Q1 2026, its #17 holding.
  • ViaWealth first reported a position in Amgen in Q4 2022 and has held it in 14 quarters since.
  • ViaWealth's Amgen position peaked at $2.43M in Q3 2024.
  • 3,130 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on ViaWealth's 13F filing for Q1 2026, filed 11 May 2026.